Dror Marchaim
Overview
Explore the profile of Dror Marchaim including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
105
Citations
1774
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Muhsen K, Schwaber M, Bishara J, Kassem E, Atamna A, Naamnih W, et al.
Front Med (Lausanne)
. 2021 Jul;
8:689994.
PMID: 34249979
This study aims to examine the prevalence and risk factors of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) sero-positivity in health care workers (HCWs), a main risk group, and assess...
12.
Zilberman-Itskovich S, Strul N, Chedid K, Martin E, Shorbaje A, Vitkon-Barkay I, et al.
Infect Control Hosp Epidemiol
. 2021 Mar;
42(9):1082-1089.
PMID: 33736724
Objective: In the era of widespread resistance, there are 2 time points at which most empiric prescription errors occur among hospitalized adults: (1) upon admission (UA) when treating patients at...
13.
Shnaiderman-Torban A, Marchaim D, Navon-Venezia S, Lubrani O, Paitan Y, Arielly H, et al.
Antibiotics (Basel)
. 2021 Feb;
10(2).
PMID: 33557061
In human medicine, infections caused by third-generation cephalosporin-resistant (3GCRE) are associated with detrimental outcomes. In veterinary medicine, controlled epidemiological analyses are lacking. A matched case-case-control investigation (1:1:1 ratio) was conducted...
14.
Cohen Mendel L, Amity K, Katz D, Lazarovitch T, Zaidenstein R, Marchaim D
Infect Control Hosp Epidemiol
. 2020 Nov;
42(6):754-759.
PMID: 33228816
A case-case-control investigation (216 patients) examined the risk factors and outcomes of carbapenem-resistant Enterobacter (CR-En) acquisition. Recent exposure to fluoroquinolones, intensive care unit (ICU) stay, and rapidly fatal McCabe condition...
15.
Adler A, Katz D, Marchaim D
Infect Dis Clin North Am
. 2020 Oct;
34(4):677-708.
PMID: 33011052
Antimicrobial resistance is a common iatrogenic complication of modern life and medical care. One of the most demonstrative examples is the exponential increase in the incidence of extended-spectrum β-lactamases (ESBLs)...
16.
Zohar Y, Itskovich S, Koren S, Zaidenstein R, Marchaim D, Koren R
Intern Emerg Med
. 2020 Sep;
16(3):719-728.
PMID: 32964373
The independent association of diabetes and hyperglycemia on the outcomes of sepsis remains unclear. We conducted retrospective cohort analyses of outcomes among patients with community-onset sepsis admitted to Shamir Medical...
17.
Bouganim R, Dykman L, Fakeh O, Motro Y, Oren R, Daniel C, et al.
Open Forum Infect Dis
. 2020 Aug;
7(8):ofaa299.
PMID: 32855986
Background: Risk factors and outcomes associated with carbapenem-resistant (CRE) acquisitions are derived primarily from cohorts consisting of carbapenemase-producing (CP) strains. Worldwide epidemiology of non-CP-CRE is evolving, but controlled epidemiological analyses...
18.
Shpunt Y, Estrin I, Levi Y, Saadon H, Ben-Yossef G, Goldshtein L, et al.
Infect Control Hosp Epidemiol
. 2020 Aug;
42(1):37-42.
PMID: 32787996
Objective: Administration of antimicrobials to patients with asymptomatic bacteriuria (ASB) is a common error that can lead to worse outcomes. However, controlled analyses quantifying the commonality and impact of this...
19.
Mills J, Kaye K, Evans R, Salzman E, Pogue J, Hayakawa K, et al.
Infect Dis Ther
. 2020 Jul;
9(3):683-690.
PMID: 32683600
Introduction: Extended-spectrum beta-lactamase (ESBL)-producing Escherichia coli infections have become endemic worldwide. We aimed to describe the molecular and clinical epidemiology of ESBL-producing E. coli infections during a period of rising...
20.
Zilberman-Itskovich S, Youngster I, Lazarovitch T, Bondarenco M, Toledano L, Kachlon Y, et al.
Future Microbiol
. 2020 Jan;
14:1489-1495.
PMID: 31913060
Recent guidelines recommended removing metronidazole as a therapeutic option for infections (CDI). However, superiority of vancomycin over metronidazole in mild CDI is not established and use of vancomycin might lead...